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Abstract 
The aim of this evidence-based practice project was to improve depression screening 
among adolescents between the ages of 12 years and 18 years using the PHQ-9 Modified Scale 
for Teens in a rural pediatric primary care clinic in Southern California. Depression is a cause of 
considerable morbidity and mortality among the pediatric population. The literature supports the 
use of depression screening tools in a variety of settings, including pediatric primary care; their 
use has shown an improvement in the detection of depression in adolescents. The American 
Academy of Pediatrics (AAP) and the U.S. Preventive Services Task Force (USPSTF) 
recommend the use of tools to screen for depression in adolescents beginning at 12 years of age. 
Screening tools for depression, specifically PHQ-9 Modified for Teens, help to identify 
depression in both the adult and pediatric populations. With its use in pediatric primary care, the 
PHQ-9 scale has been shown to have a sensitivity of 94.7% and a specificity of 86.5%. In one 
pediatric primary care clinic, four clinicians, including physicians and nurse practitioners, were 
educated about AAP depression screening guidelines and on the use and scoring of the PHQ-9 
Modified Scale for Teens. For a period of 3 months, the screening tool was used for every well-
child visit with patients between the ages of 12 years and 18 years. Baseline data were collected 
retrospectively for 3 months prior to the intervention and compared to the 3-month period 
postintervention from electronic medical record (EMR). The findings demonstrated the 
effectiveness of using the PHQ-9 Modified to detect depression in adolescents seen during a 
well-child visit. 
Keywords: adolescent depression, depression screening tool, PHQ-9, PHQ-9 modified for 
teens, AAP depression guidelines, GLAD-PC.  
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Depression is a cause of significant morbidity and mortality among the pediatric 
population. According to the World Health Organization (2020), suicide is the third leading 
cause of death in teenagers between 15 years and 19 years of age. Half of all mental health 
conditions start by the age of 14 years, but most cases go undetected and untreated. Many 
pediatric settings do not have a standardized process to screen for depression. The National 
Institute of Mental Health (2019) estimated that, in the United States, 3.2 million adolescents 12 
years to 17 years of age had at least one major depressive episode (MDE). This number 
represents 13.3% of the U.S. population for this age group. In adolescents, the 12-month 
prevalence of MDEs increased from 8.7% in 2005 to 11.5% in 2014 and in young adults 
increased from 8.8% to 9.6%; the increase was larger and statistically significant only in the age 
range of 12 years to 20 years of age. With little adaptation in mental health treatments, there is a 
growing number of adolescents who live with untreated depression (Mojtabai et al., 2016).  
The literature supported the use of depression screening tools in a variety of settings, 
including pediatric primary care and improvements have been reported in the detection of 
depression in adolescents. The American Academy of Pediatrics (AAP, 2021) and the U.S. 
Preventive Services Task Force (Siu & USPSTF, 2016) recommend the use of screening tools 
for depression in adolescents beginning at the age of 12 years and through the age of 18 years. 
With a variety of screening tools for depression, a thorough literature revealed that these tools 
help identify depression in both adults and pediatric populations, specifically the PHQ-9 
Modified for Teens tool. In the pediatric primary care setting, Libby et al. (2014) reported that 
the PHQ-9 scale had a sensitivity of 94.7% and a specificity of 86.5%.  
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Project Purpose 
 The purpose of this evidence-based project was to improve depression screening among 
adolescents between the ages of 12 years and 18 years using the PHQ-9 Modified for Teens scale 
in a rural pediatric primary care clinic in Southern California. 
Project Approval 
The medical group for one pediatric clinic wrote a letter of support approving the project 
and considering it a priority issue. The letter of support was then presented to the University of 
San Diego’s Institutional Review Board and received approval to commence the project 
(Appendix A). 
Evidence-Based Model 
 The Iowa Model Revised (Iowa Model Collaborative et al., 2017) was used for this 
evidence-based practice (EBP) project. The model provides a framework to identify a priority 
topic, form a team to gather evidence, and determined whether that evidence suggests making a 
practice change. The practice change must be consistent with the evidence and results are 
analyzed for effectiveness. The framework loop may be used for further improvements, if no or 
minimal success was shown. 
Methods 
Project Design 
This project was designed to be led by four clinicians: two nurse practitioners and two 
physicians in a rural pediatric primary care clinic. The four clinicians were educated about the 
AAP depression screening guidelines and on the use and scoring of PHQ-9 Modified for Teens 
scale. A paper copy of the screening form was to be handed out for every well-child visit with 
pediatric patients between 12 years and 18 years of age for a period of 3 months. Patients 
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completed the form, then it was reviewed by the clinician, scored, and determined if the patient 
scored positive for depression. 
Baseline data were collected retrospectively via the electronic medical record (EMR) for 
the 3-month period prior to screening implementation. That data were then compared to the 3-
month postintervention results. Data were analyzed to detect whether there was an increase in the 
detection of depression in adolescents during a well-child visit after the intervention. 
Plan for Treatment 
For adolescents screening positive for depression, the clinicians held a discussion with 
the patient and/or caregiver. In conjunction with the parent(s) and child, the clinician decided 
whether the treatment for depression would commence at the primary care clinic or if a referral 
would be made to a mental health specialist (e.g., psychiatric mental health nurse practitioner, 
psychiatrist). If parents opted out of treatment or referral, information about mental health 
services was provided (e.g., brochures, hotline phone numbers). 
Measurements  
The PHQ-9 Modified for Teens screens for mental health conditions including 
dysthymia, suicide risk, and a range of depression (i.e., mild, moderate, moderate-severe, 
severe). For the purpose of this project, the depression severity questions (Questions 1-9) were 
the focus data (American Academy of Child & Adolescent Psychiatry, n.d.). Scores of from 0-4 
points indicated no or minimal depression. A score of at least 5 points was a positive score for 
depression. Score as high as 20-27 points (severe depression) could be obtained. Questionnaires 
that had a score of 5 points or higher were included in the positive case results.  
DEPRESSION SCREENING WITH PHQ-9 MODIFIED FOR TEENS  6 
 
Data Analysis 
Intellectus Statistics software (2021) was used to analyze the data for this EBP project. 
The pre-intervention variables were age, gender, specialty referral, specialist referral, primary 
care provider (PCP) treatment, ER referral, suicidal risk, previous depression history, insurance 
type, and whether depression was identified. The post-intervention variables were a verification 
of the pre-intervention variables and the questionnaire score, if the score was positive for 
depression. 
Results 
The primary aim of this EBP project was to determine whether there was an increase in 
depression detection after the implementation of an evidence-based screening tool for 
depression. The clinic reported 865 pre-intervention patient visits in the targeted age group with 
nine of those patients scoring 5 or above on the PHQ-9 Modified. In 487 postintervention visits, 
80 patients were screened and 24 patients tested positive for depression: 13 (mild), 5 (moderate), 
5 (moderate-severe), and 1 (severe). To detect whether this represented a significant shift in the 
proportion of depression detection, a chi-squared test was conducted with significant results (χ2 = 
21.291, p < 0.001).  
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Figure 1 




The main limitation of this project was the COVID-19 pandemic. The original plan for 
this EBP project was to collect data for a longer term, preferably at least 4 months 
preintervention and 4 months post-intervention. With limited access to the physical location 
mandated by COVID-19 restrictions, outside personnel could not go on-site for data collection. 
The reduced number of patients seen postintervention was presumably the result of those 
restrictions and patients’ fear of contracting the COVID-19 virus in a community setting.  
Preintervention data were collected before the COVID-19 pandemic and post-
intervention data were collected during the pandemic. This could indicate that the rise in cases 
could be related to the pandemic environment, as children were attending school virtually. These 
adolescents were not interacting with peers as they would under normal circumstances and this 
change could have affected their state of mental health. When compared with 2019, mental 
health-related ED visits for the same period in 2020 were approximately 44% higher. During 
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2019 and 2020, adolescents 12 years to 17 years of age accounted for the largest proportion of 
pediatric mental health-related visits to the ED (Leeb et al., 2020).  
Another limitation was that preintervention and postintervention data were not collected 
during the same time of the year. Pre-intervention data consisted of visits between October 2019 
and December 2019. Post-intervention data were collected between November 2020 and 
February 2021.  
A further limitation is that the screening tool was not built into the EMR. When patients 
completed a paper copy of the PHQ-9 questionnaire for review by the clinicians, the tool was 
stored in a binder; therefore, the reliability of the screening data depended on the accurate 
storage of these sheets. Some questionnaires were incomplete and lacked information needed for 
depression scoring. 
Implications for Nursing Practice 
 Implementing a depression screening tool in a pediatric primary care setting may improve 
the identification and treatment of depression in adolescents. Consequentially, the clinic should 
be well-versed in the availability of nearby resources for referral, differences in coverage under 
various health plans, and other barriers to treatment. This EBP project suggests a higher 
proportion of teens are screening positive for depression, whether from the COVID-19 pandemic 
or improvements in depression detection, and that may affect the limited mental health resources 
in the area for appropriate and timely referrals.  
For better insight on the scope and depth of teen depression, future EBP projects could 
implement this screening tool in other settings or follow the same patients for longer periods. 
The clinic could assign resources to track the screening process, inform providers and staff about 
progress, and sustain this practice change. 
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Cost-Benefit Analysis 
 Although reimbursement rates vary, private insurers typically allocate $15 for CPT Code 
99420, Administration and interpretation of a health risk assessment instrument (e.g., health 
hazard appraisal) and Medicare pays $18 for HCPCS Code G0444, Encounter for screening for 
other disorder, one time per year (Savoy & O-Gurek, 2016). Approximately 80% of the patients 
seen at this clinic have private insurance. Therefore, an additional $14.63 of revenue could be 
generated per patient per year with PHQ-9 screening. With capitated patients, there may be a 
reduction in the number of visits to the clinic. Robinson et al. (2016) reported an increase in the 
number of visits for other complaints in patients with depression, translating to higher resource 
utilization and costs. Decreased visits, faster referral, and timelier treatment could result in a 
more efficient use of provider time, ultimately decreasing costs and resources for the clinic.  
Conclusion 
Depression is a leading cause of morbidity and mortality among adolescents in the United 
States. A literature review supported the implementation of a depression screening tool during 
well-child visits. This EBP project revealed an increased detection of depression in their 
adolescent population. The use of the PHQ-9 Modified for Teens questionnaire was shown to be 
beneficial in this rural pediatric primary care clinic. 
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